Summary:
This trial is designed to assess the efficacy, safety and tolerability of flexible dose brexpiprazole as monotherapy or as combination therapy with Zoloft (Sertraline) in adult subjects with PTSD.
This study will consist of a continuous 12-week, double-blind treatment period with a 14-day follow-up.
Qualified Participants Must:
• Be between 18 and 65 years of age
•
Trauma had to have occured in the last 15 years
Qualified Participants May Receive:
Receive compensation for time and travel. Investigational medication may be provided at no cost. Free transportation is available.